Efficacy and Safety of Favipiravir for the Treatment of COVID-19 Outpatients: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
² Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
³ Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
⁴ Department of Medicine, Mayo Hospital, Lahore, Pakistan.
⁵ Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
⁶ Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
⁷ Harvard Medical School, Boston, MA.
⁸ Department of Infectious Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, OK; and.
⁹ Department of Medicine, Section of Infectious Diseases, University of Illinois College of Medicine, Peoria.

Meta-Analysis

Huzaifa Ahmad Cheema et al. Am J Ther. 2024 May-Jun.

. 2024 May-Jun;31(3):e328-e331.

doi: 10.1097/MJT.0000000000001649. Epub 2023 Aug 29.

¹ Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
² Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
³ Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
⁴ Department of Medicine, Mayo Hospital, Lahore, Pakistan.
⁵ Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
⁶ Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
⁷ Harvard Medical School, Boston, MA.
⁸ Department of Infectious Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, OK; and.
⁹ Department of Medicine, Section of Infectious Diseases, University of Illinois College of Medicine, Peoria.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

1. Fatima M, Azeem S, Saeed J, et al. Efficacy and safety of molnupiravir for COVID-19 patients. Eur J Intern Med. 2022;102:118–121.
1. Cheema HA, Jafar U, Sohail A, et al. Nirmatrelvir–ritonavir for the treatment of COVID‐19 patients: a systematic review and meta‐analysis. J Med Virol. 2023;95:e28471.
1. Cheema HA, Jafar U, Elrashedy AA, et al. Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: a systematic review and meta-analysis. J Infect. 2022;85:702–769.
1. Cheema HA, Shafiee A, Athar MMT, et al. No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis. J Infect. 2023;86:154–225.
1. Cheema HA, Sohail A, Fatima A, et al. Quercetin for the treatment of COVID‐19 patients: a systematic review and meta‐analysis. Rev Med Virol. 2023;33:e2427.